Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 17.85 is in line with its 5-year average of 17.78, around the middle of its 5-year range (12.81–26.23).
As of the fiscal period ended Tuesday, June 30, 2026. 8.97% above its 12-month average of 16.38.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 17.85.
QUICK RATIO (ACID-TEST)
17.85
QUICK RATIO (ACID-TEST) AVG TTM
16.38
QUICK RATIO (ACID-TEST) AVG 3Y
16.22
QUICK RATIO (ACID-TEST) AVG 5Y
17.78
QUICK RATIO (ACID-TEST) AVG 10Y
16.63
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.97%
CURRENT VS 3Y AVG
+10.02%
CURRENT VS 5Y AVG
+0.40%
CURRENT VS 10Y AVG
+7.30%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.28
median of 97 covered companies
CURRENT VS SECTOR MEDIAN
+1294.28%
vs the sector median at left
CRISPR Therapeutics AG
Market Cap
$5.35B
Quick Ratio (Acid-Test)
17.85
TTM Avg
16.38
3Y Avg
16.22
5Y Avg
17.78
Market Cap
$5.10B
Quick Ratio (Acid-Test)
2.79
TTM Avg
2.90
3Y Avg
2.74
5Y Avg
2.21
Market Cap
$5.61B
Quick Ratio (Acid-Test)
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$6.47B
Quick Ratio (Acid-Test)
0.87
TTM Avg
1.56
3Y Avg
2.48
5Y Avg
3.39
Market Cap
$6.63B
Quick Ratio (Acid-Test)
0.89
TTM Avg
1.19
3Y Avg
1.21
5Y Avg
1.11
Market Cap
$2.76B
Quick Ratio (Acid-Test)
6.07
TTM Avg
7.05
3Y Avg
8.10
5Y Avg
8.04
Market Cap
$8.02B
Quick Ratio (Acid-Test)
1.08
TTM Avg
0.93
3Y Avg
1.08
5Y Avg
1.24
Market Cap
$2.52B
Quick Ratio (Acid-Test)
14.57
TTM Avg
8.96
3Y Avg
7.17
5Y Avg
6.28
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | $5.35B | 17.85 | 16.38 | 16.22 | 17.78 |
| Doximity, Inc. (DOCS)vs › | $5.22B | 6.08 | 6.53 | 6.56 | 6.07 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 2.79 | 2.90 | 2.74 | 2.21 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | 7.02 | 8.28 | 8.59 | 7.77 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | 0.87 | 1.56 | 2.48 | 3.39 |
| Chemed Corporation (CHE)vs › | $6.63B | 0.89 | 1.19 | 1.21 | 1.11 |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 6.07 | 7.05 | 8.10 | 8.04 |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 1.08 | 0.93 | 1.08 | 1.24 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | 14.57 | 8.96 | 7.17 | 6.28 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | 5.03 | 4.66 | 4.92 | 7.11 |
Quick Ratio
17.85
Excludes inventory
Current Ratio
17.85
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 17.85 |
| 2026-03-31 | 17.96 |
| 2025-12-31 | 13.25 |
| 2025-09-30 | 16.22 |
| 2025-06-30 | 16.61 |
| 2025-03-31 | 15.64 |
| 2024-12-31 | 22.07 |
| 2024-09-30 | 21.64 |
| 2024-06-30 | 15.73 |
| 2024-03-31 | 17.81 |
| 2023-12-31 | 17.54 |
| 2023-09-30 | 15.83 |
| 2023-06-30 | 14.00 |
| 2023-03-31 | 13.00 |
| 2022-12-31 | 15.30 |
| 2022-09-30 | 12.81 |
| 2022-06-30 | 17.57 |
| 2022-03-31 | 19.88 |
| 2021-12-31 | 20.17 |
| 2021-09-30 | 26.18 |
| 2021-06-30 | 26.23 |
| 2021-03-31 | 22.05 |
| 2020-12-31 | 18.21 |
| 2020-09-30 | 16.53 |
| 2020-06-30 | 12.96 |
| 2020-03-31 | 16.87 |
| 2019-12-31 | 17.29 |
| 2019-09-30 | 8.32 |
| 2019-06-30 | 13.96 |
| 2019-03-31 | 15.84 |
| 2018-12-31 | 16.81 |
| 2018-09-30 | 15.39 |
| 2018-06-30 | 17.89 |
| 2018-03-31 | 24.42 |
| 2017-12-31 | 17.12 |
| 2017-09-30 | 21.34 |
| 2017-06-30 | 17.79 |
| 2017-03-31 | 17.53 |
| 2016-12-31 | 14.56 |
| 2016-09-30 | 2.97 |
| 2016-06-30 | 3.09 |
| 2016-03-31 | 2.68 |
| 2015-12-31 | 15.44 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
